TY - JOUR
T1 - Manifestaciones neuropsiquiátricas y cognitivas en demencia frontotemporal y esclerosis lateral amiotrófica
T2 - Dos polos de una entidad común
AU - Lillo, Patricia
AU - Matamala, José Manuel
AU - Valenzuela, Daniel
AU - Verdugo, Renato
AU - Castillo, José Luis
AU - Ibáñez, Agustín
AU - Slachevsky, Andrea
AU - Slachevsky, Andrea
N1 - Publisher Copyright:
© 2014, Sociedad Medica de Santiago. All rights reserved.
PY - 2014/7/1
Y1 - 2014/7/1
N2 - Recent genetic and neuropathologic advances support the concept that frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are overlapping multisystem disorders. While 10-15% of ALS patients fulfil criteria for FTD, features of motor neuron disease appear in approximately 15% of FTD patients, during the evolution of the disease. This overlap has been reinforced by the discovery of Transactive Response DNA Binding Protein 43 kDa (TDP43) inclusions as the main neuropathologic finding in the majority of ALS cases and almost a half of FTD cases. Also, an expansion in the intron of C9ORF72 (chromosome 9p21) has been identified in families affected by ALS, ALS-FTD and FTD. This review provides an update on the recent genetic and neuropathologic findings of ALS and FTD and a characterization of their clinical presentation forms, based on the current diagnostic criteria. Finally it underscores the importance of having a national registry of patients with ALS and FTD, to provide an earlier diagnosis and a multidisciplinary care.
AB - Recent genetic and neuropathologic advances support the concept that frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are overlapping multisystem disorders. While 10-15% of ALS patients fulfil criteria for FTD, features of motor neuron disease appear in approximately 15% of FTD patients, during the evolution of the disease. This overlap has been reinforced by the discovery of Transactive Response DNA Binding Protein 43 kDa (TDP43) inclusions as the main neuropathologic finding in the majority of ALS cases and almost a half of FTD cases. Also, an expansion in the intron of C9ORF72 (chromosome 9p21) has been identified in families affected by ALS, ALS-FTD and FTD. This review provides an update on the recent genetic and neuropathologic findings of ALS and FTD and a characterization of their clinical presentation forms, based on the current diagnostic criteria. Finally it underscores the importance of having a national registry of patients with ALS and FTD, to provide an earlier diagnosis and a multidisciplinary care.
KW - Amyothrophic lateral sclerosis
KW - Frontotemporal dementia
KW - Motor neuron disease
UR - http://www.scopus.com/inward/record.url?scp=84908165153&partnerID=8YFLogxK
U2 - 10.4067/S0034-98872014000700007
DO - 10.4067/S0034-98872014000700007
M3 - Article
C2 - 25378006
AN - SCOPUS:84908165153
SN - 0034-9887
VL - 142
SP - 867
EP - 879
JO - Revista Medica de Chile
JF - Revista Medica de Chile
IS - 7
ER -